Green Cross Medical Science Corporation - Asset Resilience Ratio

Latest as of June 2023: 9.78%

Green Cross Medical Science Corporation (142280) has an Asset Resilience Ratio of 9.78% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩9.41 Billion

≈ $6.38 Million USD Cash + Short-term Investments

Total Assets

₩96.24 Billion

≈ $65.22 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Green Cross Medical Science Corporation's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Green Cross Medical Science Corporation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Green Cross Medical Science Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Green Cross Medical Science Corporation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩9.41 Billion	9.78%
Short-term Investments	₩0.00	0%
Total Liquid Assets	₩9.41 Billion	9.78%

Asset Resilience Insights

Limited Liquidity: Green Cross Medical Science Corporation maintains only 9.78% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Green Cross Medical Science Corporation Industry Peers by Asset Resilience Ratio

Compare Green Cross Medical Science Corporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Green Cross Medical Science Corporation (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Green Cross Medical Science Corporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	₩0.00 ≈ $0.00	₩90.53 Billion ≈ $61.35 Million	--
2022-12-31	11.14%	₩10.75 Billion ≈ $7.28 Million	₩96.47 Billion ≈ $65.38 Million	+9.22pp
2021-12-31	1.92%	₩1.84 Billion ≈ $1.25 Million	₩95.63 Billion ≈ $64.81 Million	-2.34pp
2020-12-31	4.26%	₩4.50 Billion ≈ $3.05 Million	₩105.60 Billion ≈ $71.57 Million	-11.14pp
2019-12-31	15.40%	₩13.68 Billion ≈ $9.27 Million	₩88.87 Billion ≈ $60.22 Million	+1.40pp
2018-12-31	13.99%	₩8.95 Billion ≈ $6.07 Million	₩63.97 Billion ≈ $43.35 Million	+8.04pp
2017-12-31	5.95%	₩3.60 Billion ≈ $2.44 Million	₩60.54 Billion ≈ $41.03 Million	+2.10pp
2016-12-31	3.85%	₩2.45 Billion ≈ $1.66 Million	₩63.61 Billion ≈ $43.10 Million	--

pp = percentage points

About Green Cross Medical Science Corporation

KQ:142280 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$36.69 Million

₩54.14 Billion KRW

Market Cap Rank

#23000 Global

#1489 in Korea

Share Price

₩2490.00

Change (1 day)

+0.00%

52-Week Range

₩2395.00 - ₩6230.00

All Time High

₩19450.00